Clinical Trials Directory

Trials / Conditions / Recurrent Diffuse Intrinsic Pontine Glioma

Recurrent Diffuse Intrinsic Pontine Glioma

7 registered clinical trials studyying Recurrent Diffuse Intrinsic Pontine Glioma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingLutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
NCT05278208
Nationwide Children's HospitalPhase 1 / Phase 2
RecruitingCBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
NCT04870944
Children's Oncology GroupPhase 1 / Phase 2
RecruitingCombination Therapy for the Treatment of Diffuse Midline Gliomas
NCT05009992
University of California, San FranciscoPhase 2
Active Not RecruitingVolitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
NCT03598244
National Cancer Institute (NCI)Phase 1
CompletedHypofractionated Radiotherapy for Recurrent DIPG
NCT03841435
University of CincinnatiN/A
CompletedRibociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
NCT03387020
Pediatric Brain Tumor ConsortiumPhase 1
Active Not RecruitingPembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diff
NCT02359565
National Cancer Institute (NCI)Phase 1